These include PCDHGA3, hypermethylated in 24/27 tumours (89%), PCDHGB4 (23/25, 92%), PCDHGA2 (11/13, 85%) and PCDHB3 (21/33, 64%). Here, PCDHGA2 is linked to neoplasm.